QC
OSG

Quantessence Capital’s Octave Specialty Group OSG Stock Holding History

Quantessence Capital’s Portfolio OSG Stock Details OSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,500
Closed -$206K – 195
2025
Q1 		$206K Buy
+23,500
New +$248K 0.05% 277

Other funds holding OSG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CGIC
Continental General Insurance Company Austin, Texas $693M AUM 90.58% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCC
Bain Capital Credit Boston, Massachusetts $303M AUM 15.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantessence Capital's OSG Position: Q2 2025 in Review

Quantessence Capital sold out of Octave Specialty Group (OSG) in Q2 2025, closing a stake of 23,500 shares — an estimated $206K sold.

Quantessence Capital first reported a position in OSG in Q1 2025 and held it in 1 quarter. The position peaked at $206K in Q1 2025. 146 funds tracked by Wall St. Rank hold OSG as of Q2 2025.

  • Quantessence Capital reported no remaining Octave Specialty Group position as of Q2 2025 after selling out during the quarter.
  • Quantessence Capital sold 23,500 Octave Specialty Group shares in Q2 2025, an estimated $206K.
  • Quantessence Capital first reported a position in Octave Specialty Group in Q1 2025 and held it in 1 quarter.
  • Quantessence Capital's Octave Specialty Group position peaked at $206K in Q1 2025.
  • 146 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.